Validation of Ovarian Adnexal Mass Assessment Score Test System
-
StatusAccepting Candidates
-
Age18 Years - 99 Years
-
SexesFemale
-
Healthy Volunteers
Description
This study is designed to evaluate the clinical performance of CleoDX’s Ovarian Adnexal Mass Assessment Score Test System as a pre-surgical diagnostic aid for patients with adnexal masses. The goal of the test is to enhance pre-surgical workflows by aiding in the identification of potential malignancies and optimizing the clinical referral process. This study involves the collection of a single blood sample and post-surgical data. Blood samples will undergo testing for follicle-stimulating hormone (FSH) levels and the CleoDX Ovarian Adnexal Mass Score.
Details
Protocol number | CSP-01-001 |
Eligibility
Inclusion Criteria
Participants must meet the following criteria to be eligible for participation:
- Are female patients ≥ 18 years of age at the time of consent
- Can provide written informed consent
- Have an ovarian cyst or adnexal mass identified through radiological imaging that requires surgery, but has not yet undergone this surgery
Exclusion Criteria
Participants will be excluded from the study if they meet any of the following criteria:
- Any prior confirmed diagnosis of, or treatment for, ovarian cancer
- Any prior surgery resulting in removal of both ovaries (bilateral oophorectomy)
- Prior history of gynecological malignancy (within last 2 years)
- Prior history of melanoma (within last 2 years). Prior treatment (within 12 months of sample collection) with chemotherapy, radiotherapy or immunotherapy
- Immune-compromised
- Pregnant currently or within the last 3 months based on participant-reported feedback.
Lead researchers
-
Isidore D Benrubi, MD, MPHGynecologic Oncologist
-
Karina E Hew, MDGynecologic Oncologist
Participate in a study
Here are some general steps to consider when participating in a research study:
-
Step1
Contact the research team
Call or email the research team listed within the specific clinical trial or study to let them know that you're interested. A member of the research team, such as the researcher or study coordinator, will be available to tell you more about the study and to answer any questions or concerns you may have.
Primary contact
-
Step2
Get screened to confirm eligibility
You may be asked to take part in prescreening to make sure you are eligible for a study. The prescreening process ensures it is safe for you to participate. During the prescreening process, you will be asked some questions and you may also be asked to schedule tests or procedures to confirm your eligibility.
-
Step3
Provide your consent to participate
If you are eligible and want to join the clinical trial or study, a member of the research team will ask for your consent to participate. To give consent, you will be asked to read and sign a consent form for the study. This consent form explains the study's purpose, procedures, risks, benefits and provides other important information, such as the study team's contact information.
-
Step4
Participate
If you decide to participate in a clinical trial or study, the research team will keep you informed of the study requirements and what you will need to do to throughout the study. For some trials or studies, your health care provider may work with the research team to ensure there are no conflicts with other medications or treatments.